AstraZeneca opened a new global strategic research and development center in Kendall Square, Cambridge, Massachusetts

Statements (3)

1. ▲ Bullish

   AstraZeneca is investing over $1 billion in its Massachusetts operations

   breakingthenews.netOct 5, 2026 16:20 UTCHigh importance
2. ● Neutral

   AstraZeneca is opening a new R&D center in Massachusetts as part of a $1 billion investment

   reuters.comOct 5, 2026 16:19 UTC
3. ● Neutral

   AstraZeneca opened a new global strategic research and development center in Kendall Square, Cambridge, Massachusetts

   businesswire.comOct 5, 2026 16:01 UTC